These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29859522)

  • 1. [The relationship between catechol O-methyltransferase and diseases].
    Qian XK; Xia YL; Dou TY; Hou J; Ma H; Ge GB; Yang L; Bi XL
    Yao Xue Xue Bao; 2016 Apr; 51(4):543-51. PubMed ID: 29859522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis.
    Zhu BT
    Curr Drug Metab; 2002 Jun; 3(3):321-49. PubMed ID: 12083324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
    Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detoxication of structurally diverse polycyclic aromatic hydrocarbon (PAH) o-quinones by human recombinant catechol-O-methyltransferase (COMT) via O-methylation of PAH catechols.
    Zhang L; Jin Y; Chen M; Huang M; Harvey RG; Blair IA; Penning TM
    J Biol Chem; 2011 Jul; 286(29):25644-54. PubMed ID: 21622560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols.
    Sak K
    Drug Metab Rev; 2017 Feb; 49(1):56-83. PubMed ID: 27826992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols.
    Ovaska M; Yliniemelä A
    J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility.
    Kiss LE; Soares-da-Silva P
    J Med Chem; 2014 Nov; 57(21):8692-717. PubMed ID: 25080080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution, properties, and inhibitor sensitivity of zebrafish catechol-O-methyl transferases (COMT).
    Semenova S; Rozov S; Panula P
    Biochem Pharmacol; 2017 Dec; 145():147-157. PubMed ID: 28844929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization of catechol-O-methyltransferase in neoplastic and nonneoplastic mammary epithelial cells.
    Weisz J; Fritz-Wolz G; Gestl S; Clawson GA; Creveling CR; Liehr JG; Dabbs D
    Am J Pathol; 2000 Jun; 156(6):1841-8. PubMed ID: 10854207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitors.
    Ellermann M; Lerner C; Burgy G; Ehler A; Bissantz C; Jakob-Roetne R; Paulini R; Allemann O; Tissot H; Grünstein D; Stihle M; Diederich F; Rudolph MG
    Acta Crystallogr D Biol Crystallogr; 2012 Mar; 68(Pt 3):253-60. PubMed ID: 22349227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
    Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells.
    Lehmann L; Jiang L; Wagner J
    Carcinogenesis; 2008 Feb; 29(2):363-70. PubMed ID: 18192686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemistry and pharmacology of catechol-O-methyltransferase inhibitors.
    Nissinen E; Männistö PT
    Int Rev Neurobiol; 2010; 95():73-118. PubMed ID: 21095460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
    Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
    Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.
    Lewandowski KE
    Harv Rev Psychiatry; 2007; 15(5):233-44. PubMed ID: 17924258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
    Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
    Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel human catechol-O-methyl-transferase mutant with triplet point mutations.
    Bai HW; Wang P; Zhu BT
    Int J Mol Med; 2008 Dec; 22(6):769-79. PubMed ID: 19020775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
    Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal Structure of Catechol O-Methyltransferase Complexed with Nitecapone.
    Iijima H; Takebe K; Suzuki M; Kobayashi H; Takamiya T; Saito H; Niwa N; Kuwada-Kusunose T
    Chem Pharm Bull (Tokyo); 2020; 68(5):447-451. PubMed ID: 32378542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.